These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9691631)

  • 1. [Thromboxane A2 production in the pathogenesis of diabetic complications].
    Napoli E; Franco N
    Minerva Endocrinol; 1998 Mar; 23(1):1-5. PubMed ID: 9691631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin E on platelet aggregation in diabetes mellitus.
    Watanabe J; Umeda F; Wakasugi H; Ibayashi H
    Thromb Haemost; 1984 Jul; 51(3):313-6. PubMed ID: 6495252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in cytosolic free calcium and thromboxane B2 synthesis in platelets from diabetic subjects].
    Cai D; Yu B; Yan T
    Zhonghua Yi Xue Za Zhi; 1995 Aug; 75(8):476-8, 510-1. PubMed ID: 7584570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
    Awad AS; Webb RL; Carey RM; Siragy HM
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):544-8. PubMed ID: 15831366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
    Naveh-Floman N; Moisseiev J
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):321-5. PubMed ID: 6764248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
    Ferlito S; Gallina M
    Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies].
    Sergienko AA
    Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
    Biesenbach G; Königsrainer A; Gross C; Margreiter R
    Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications in the TXA(2) and PGI(2) plasma levels and some other biochemical parameters during the initiation and development of non-insulin-dependent diabetes mellitus (NIDDM) syndrome in the rabbit.
    Lasserre B; Navarro-Delmasure C; Pham Huu Chanh A; Catala J; Hollande E
    Prostaglandins Leukot Essent Fatty Acids; 2000 May; 62(5):285-91. PubMed ID: 10883059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay measurement of thromboxane B2 in human plasma and urine.
    Hornych A; Krief C; Bariety J
    Prostaglandins Leukot Med; 1982 May; 8(5):467-80. PubMed ID: 6954551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats.
    Ajayi AA; Ogungbade GO; Okorodudu AO
    Eur J Clin Invest; 2004 May; 34(5):349-57. PubMed ID: 15147332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins.
    Bagi Z; Erdei N; Toth A; Li W; Hintze TH; Koller A; Kaley G
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1610-6. PubMed ID: 15947245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.